3.44
price up icon3.61%   0.12
 
loading
Schlusskurs vom Vortag:
$3.32
Offen:
$3.36
24-Stunden-Volumen:
33,333
Relative Volume:
0.67
Marktkapitalisierung:
$18.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.35M
KGV:
-1.1279
EPS:
-3.05
Netto-Cashflow:
$-11.88M
1W Leistung:
+10.42%
1M Leistung:
+6.50%
6M Leistung:
-26.65%
1J Leistung:
-40.89%
1-Tages-Spanne:
Value
$3.30
$3.60
1-Wochen-Bereich:
Value
$3.10
$3.60
52-Wochen-Spanne:
Value
$2.6838
$6.1683

Lipocine Inc Stock (LPCN) Company Profile

Name
Firmenname
Lipocine Inc
Name
Telefon
801 994 7383
Name
Adresse
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Name
Mitarbeiter
16
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
LPCN's Discussions on Twitter

Vergleichen Sie LPCN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LPCN
Lipocine Inc
3.44 17.76M 0 -16.35M -11.88M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Lipocine Inc Stock (LPCN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-06-24 Eingeleitet Cantor Fitzgerald Overweight
2020-12-10 Hochstufung Ladenburg Thalmann Neutral → Buy
2018-01-12 Bestätigt H.C. Wainwright Buy
2018-01-11 Herabstufung Canaccord Genuity Buy → Hold
2017-12-08 Fortgesetzt H.C. Wainwright Buy
2016-10-07 Eingeleitet H.C. Wainwright Buy
2015-07-22 Eingeleitet ROTH Capital Buy
2015-06-23 Eingeleitet Canaccord Genuity Buy
Alle ansehen

Lipocine Inc Aktie (LPCN) Neueste Nachrichten

pulisher
Jul 25, 2025

What analysts say about Lipocine Inc. stockHigh-impact stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Lipocine Inc. stock priceUnstoppable investment returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

How Lipocine Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

Is Lipocine Inc. a good long term investmentFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Lipocine Inc. Stock Analysis and ForecastSpectacular growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

What makes Lipocine Inc. stock price move sharplyTrade With Low Risk Exposure - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Lipocine Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Lipocine stock maintains Buy rating at H.C. Wainwright on PPD treatment potential - Investing.com Australia

Jul 11, 2025
pulisher
Jun 30, 2025

Lipocine stock maintains Buy rating at H.C. Wainwright as Phase 3 trial begins - Investing.com

Jun 30, 2025
pulisher
Jun 27, 2025

First Patient Receives Lipocene's LPCN 1154 for Postpartum Depression in Phase 3 Clinical Trial - Patient Care Online

Jun 27, 2025
pulisher
Jun 26, 2025

LPCN Begins Pivotal Phase 3 Trial for Postpartum Depression Treatment | LPCN Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression - Financial Times

Jun 26, 2025
pulisher
Jun 23, 2025

Lipocine to Host R&D Event on July 9 - TipRanks

Jun 23, 2025
pulisher
Jun 12, 2025

HC Wainwright Estimates Lipocine’s Q1 Earnings (NASDAQ:LPCN) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Lipocine (NASDAQ:LPCN) Given Buy Rating at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

LPCN Stock Maintains 'Buy' Rating with $8.00 Price Target | LPCN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Lipocine partner files for Canadian approval of oral TRT drug By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Verity Pharma Files TLANDO Drug Submission In Canada For Lipocine - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

LPCN: Lipocine's TRT Submission in Canada Marks Key Milestone | - GuruFocus

Jun 09, 2025

Finanzdaten der Lipocine Inc-Aktie (LPCN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):